Study of prevalence and impact of hyperuricemia in a patient of hypertension
Keywords:Hyperuricemia, Hypertension, JNC VII, Serum uric acid
Background: The association of raised serum uric acid levels with various cardiovascular risk factors has often led to the debate of whether raised serum uric acid levels could be an independent risk factor in essential hypertension. Hence we carried out a study to examine the possibility of hyperuricemia causing hypertension, to see if there is a relationship between the serum uric acid levels and severity and duration of hypertension.
Methods: The study was carried out in Smt. SCL Hospital, Saraspur, Ahmedabad, India, the study period from September 2012 to June 2014, a total of 100 patients were studied. The patients were included if they satisfied the JNC VII criteria for hypertension. They were excluded if they were having any other condition known to cause raised serum uric acid levels and secondary hypertension.
Results: With the result based on the study carried out we concluded that there can be a direct relation between hyperuricemia and hypertension. Also the study showed that the SUA levels were significantly increased in patient with stage 2 hypertension in comparasion with those with stage 1 hypertension, showing that the severity of hypertension also related to the SUA levels.
Conclusions: Based on the study carried out we concluded that SUA can be used as an early biochemical marker to determine the severity and duration of hypertension.
World Health report. Reducing risks and promoting healthy life Geneva, Switzerland: World Health Organization, 2002. Available at http://www.who. int/whr/2002. Accessed on 12 July 2016.
Cutler JA. High blood pressure and end organ damage. J Hypertens. 1996;14(6):3-6.
Jhonson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003;41:1183-90.
Swales JD. Manual of hypertension. In Oxford: Blackwell science. 1995.
Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, et al. Elevated uric acid increased blood pressure in the rat by novel crystal independent mechanism. Hypertension. 2001;38:1101-6.
Chobanian AV, Bakris GL. The seventh report of the joint National committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA. 2003;21(289);2561-2.
Vasan RS, Larson MG, Leip EP. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham heart study. Lancet. 2001;358:1682-6.
Breckenridge A. Hypertension and hyperuricemia. The Lancet. 1966:287;15-8.
Bonora E, Targher G, Zenere MB, Saggiani F, Cacciatori V, Tosi F, et al. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona young men atherosclesosis risk factor study. Int J Obesity Relat Metab Disord. 1996;20:975-80.
Malinow MR, Levenson J, Giral P, Nieto FJ, Razavian M, Segond P, et al. Role of blood pressure, uric acid, and hemorheological parameters on plasma homocyst(e)ine concentration. Atherosclerosis. 1995;114:175-83.
Woo J, Swaminanthan R, Cockram C, Lau E, Chan A. Association between serum uric acid and some cardiovascular risk factors in a Chinese population. Postgard Med J. 1994;70:486-91.
Systemic Hypertension. Available at http://fqz301.brinkster.net/Braunwald%20Heart%20Disease%207thew/heart%207th%20by%20FengQZ%202005-07-02/html/436.html. Accessed on 12 July 2016.
Jacques BC, Ginsberg MH. The role of cell surface proteins in platelet stimulation by monosodium urate crystals. Arthritis Rheumatology. 1982;25:508-21.
Kinsey D, Walther R, Wise HS, Smithwick R. Incidence of hyperuricemia in 400 hypertensive patients. Circulation. 1961;24:972.
Kolbel F, Gregorova I, Souka J. Serum uric acid in hypertensives. Lancet. 1965;1:519.
Bulpitt CJ. Serum uric acid in hypertensive patients. British Heart J. 1975;37:1210-5.
Ramsay L. Hyperuricemia in hypertension, role of alcohol. British Med J. 1979;1:653-4.